# FDA recall D-1584-2014

> **Taro Pharmaceuticals U.S.A., Inc.** · Class III · drug recall initiated 2014-08-25.

## Product

Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd.,  Haifa Bay, Israel 26110.  Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.

## Reason for recall

Failed Content Uniformity Specifications.

## Distribution

United States including: OH, HI, NH, MS, IL, TX, CA.

## Key facts

- **Recall number:** D-1584-2014
- **Recalling firm:** Taro Pharmaceuticals U.S.A., Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-08-25
- **Report date:** 2014-09-24
- **Termination date:** 2018-05-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Hawthorne, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1584-2014

## Citation

> AI Analytics. FDA recall D-1584-2014. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1584-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*